The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. FLXN Buy or Sell? Investors can use this forecasting interface to forecast Flexion Therapeutics historical stock prices and determine the direction of Flexion Therapeutics's future trends based on various well-known forecasting models. Over the last 12 months, FLXN stock rose by 26.05%. FLXN -- USA Stock : USD 11.79 0.40 3.28% : Flexion Therapeutics Stock Forecast is based on your current time horizon. Flexion Therapeutics Inc stock has gained 61.23% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary scoring system, gives FLXN stock a score of 74 out of a possible 100.. That score is influenced by a long-term technical score of 88. FLXN | Complete Flexion Therapeutics Inc. stock news by MarketWatch. An important predictor of whether a stock price will go up is its track record of momentum. Investors can use this forecasting interface to forecast Flexion Therapeutics historical stock prices and determine the direction of Flexion Therapeutics's future trends based on various well-known forecasting models. In the short term (2weeks), FLXN's stock price should outperform the market by 1.22%.During that period the price should oscillate between -9.81% and +11.13%.. Get a free FLXN technical analysis report to make a better FLXN stock predictions on how the stock will perform in the near future. In the latest trading session, 2,306,026 BioNTech SE(NASDAQ:BNTX) shares changed hands as the company’s beta touched 0. Forecast for Fri 18 Sep 2020 price 12.62 FLEXION THERAPEUTICS INC stock price forecast for further price development up to 2.40% (time horizon: 1 day) and price target of 12.62 USD. FLXN Buy or Sell?Find out if you should buy FLXN stock. Price trends tend to persist, so it's worth looking at them when it comes to a share like Flexion Therapeutics Inc. Over the past six months, the relative strength of its shares against the market has been -13.28%. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). FLXN 10.82 0.02 (0.19%). Negative news sentiment. So, when comparing one stock to another in a different industry, it's best make relative comparisons to that stock's respective industry values. The average price target represents a 113.02% upside from the last price of $10.40. What this means: Flexion Therapeutics (FLXN) gets an Overall Rank of 61, which is an above average rank under InvestorsObserver's stock ranking system. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. The FLXN stock forecast is provided by MarketClub with their Trade Triangle system.. FLXN Stock … About the Flexion Therapeutics, Inc stock forecast. FLEXION THERAPEUTICS INC stock prediction: up to 12.62 USD FLXN stock price prognosis STOCK. Flexion Therapeutics. View real-time stock prices and stock quotes for a full financial overview. FLXN -- USA Stock : USD 11.51 0.20 1.77% : Flexion Therapeutics Stock Forecast is based on your current time horizon. FLXN -- USA Stock : USD 10.84 0.23 2.08% : Flexion Therapeutics Stock Forecast is based on your current time horizon. FLXN stock charts overview Should I buy Flexion Therapeutics stock? Flexion (FLXN) Stock Plunged Today After Announcing Stock Offering. FLXN Stock Analysis Overview . FLXN stock forecast Our latest prediction for Flexion Therapeutics, Inc.'s stock price was made on the May 26, 2020 when the stock price was at 9.69$.. The report will be for the fiscal Quarter ending Sep 2020. By Rachel Graf. The average price target is $22.15, with a high forecast of $35.00 and a low forecast of $15.00. Find the latest Flexion Therapeutics, Inc. (FLXN) stock quote, history, news and other vital information to help you with your stock trading and investing. Flexion Therapeutics Inc (FLXN:NMQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Jun 8, 2016 4:11 PM EDT. A high-level overview of Flexion Therapeutics, Inc. (FLXN) stock. Trade these 7 under-$10 stocks for breakout gains. To hit the forecast high, the stock’s price needs a +223.48% upsurge from its current level, while the stock would need to tank 47.87% for it to hit the projected low. The one-year Flexion Therapeutics Inc. stock forecast points to a potential upside of 41.21. OPINION. Stock Price Forecast The 12 analysts offering 12-month price forecasts for Flexion Therapeutics Inc have a median target of 19.00, with a high estimate of 35.00 and a low estimate of 15.00. Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. This price target is based on 13 analysts offering 12 month price targets for Flexion Therapeutics in the last 3 months. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart Find real-time HLX - Helix Energy Solutions Group Inc stock quotes, company profile, news and forecasts from CNN Business. FLXN's score also includes a short-term technical score of 86. View Flexion Therapeutics, Inc. FLXN investment & stock information. -174.25% -113.38% The average equity rating for FLXN stock is currently 1.80, trading closer to a bullish pattern in the stock market. FLXN - Flexion Therapeutics Inc. FLXN Stock Trend. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Based on 12 analysts offering 12 month price targets for ViacomCBS in the last 3 months. With the company’s most recent per share price at $102.37 changing hands around -$4.13 or -0.04% at last look, the market valuation stands at $24.62 Billion. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Earnings results for Flexion Therapeutics (NASDAQ:FLXN) Flexion Therapeutics, Inc. is expected* to report earnings on 11/04/2020 after market close. Flexion Therapeutics's earnings in 2020 is -$127,575,000.On average, 4 Wall Street analysts forecast FLXN's earnings for 2020 to be $-128,052,568, with the lowest FLXN earnings fo Get the latest Flexion Therapeutics, Inc. FLXN detailed stock quotes, stock … The median estimate represents a +75.44% increase from the last price of 10.83. Flexion (FLXN) Soars: Stock Adds 6.6% in Session Zacks Equity Research - Zacks Investment Research - Thu May 28, 8:13AM CDT Zacks Equity Research - ZACKS - Thu May 28, 8:13AM CDT Flexion (FLXN) saw a big move last session, as its shares jumped more … flxn $11.36 $0.27 2.4% Price as of November 20, 2020, 9:00 p.m. EST View Interactive FLXN Charts According to analyst projections, FLXN’s forecast low is $16 with $35 as the target high. Given the current horizontal trend, you can expect Flexion Therapeutics stock with a 90% probability to be traded between $10.27 and $13.58 at the end of this 3-month period. According to Zacks Investment Research, based on 4 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.49. Find the latest analyst research for Flexion Therapeutics, Inc. Common Stock (FLXN) at Nasdaq.com. Post-Market 0.00 (0.00%) But as that field narrows, FLX is worth a look. Forecast Cash Runway: Insufficient data to determine if FLXN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates. View the latest Flexion Therapeutics Inc. (FLXN) stock price, news, historical charts, analyst ratings and financial information from WSJ. The average price target is $31.25 with a high forecast of $36.00 and a low forecast of $26.00.The average price target represents a -10.25% decrease from the last price of $34.82. Investors can use this forecasting interface to forecast Flexion Therapeutics historical stock prices and determine the direction of Flexion Therapeutics's future trends based on various well-known forecasting models. Investors can use this forecasting interface to forecast Flexion Therapeutics historical stock prices and determine the direction of Flexion Therapeutics's future trends based on various well-known forecasting models. See Flexion Therapeutics, Inc. (FLXN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. FLXN stock has been falling because the company is not in the race for a Covid-19 vaccine. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. As of 2020 September 23, Wednesday current price of FLXN stock is 11.070$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Flexion Therapeutics stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. Stock Market Forecast: I Know First S&P 500 & Nasdaq Evaluation Report – Accuracy Up To 72% Top S&P 500 Stocks Performance Report By Day Of The Week By I Know First Evaluation MU Stock Forecast: I Know First Stock Forecasts Evaluation Report FLXN -- USA Stock : USD 13.08 0.42 3.11% : Flexion Therapeutics Stock Forecast is based on your current time horizon. 5 Biotech Stocks That Could Be the Next Amgen. Next Steps Explore more healthy companies in the Pharmaceuticals & Biotech industry.